Latest Investigational New Drug Stories
NEW BRUNSWICK, N.J., May 7, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced a first-of-its-kind partnership that enlists a third party to review requests made to the Janssen
MENLO PARK, Calif., March 18, 2015 /PRNewswire/ -- BioPharmX Corporation (OTCQB: BPMX), a specialty pharmaceutical company focused on the development of novel drug delivery products to address
SAN DIEGO, March 11, 2015 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), a leader in the discovery and development of lipid-targeted therapeutics, announced that the U.S.
WEST HAVEN, Conn., Feb. 25, 2015 /PRNewswire/ -- NanoViricides, Inc.
BEVERLY HILLS, Calif., Feb. 4, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc.
SAN DIEGO, Feb. 2, 2015 /PRNewswire/ -- Lpath, Inc.
MONTREAL, Jan. 12, 2015 /PRNewswire/ - Milestone Pharmaceuticals, Inc. announced today that it received clearance of its Investigational New Drug (IND) Application from the U.S.
Biohaven filed a pre-IND meeting request with the FDA regarding lead investigational agent BHV-0223, receives written response in lieu of an in-person meeting TORONTO, Dec.
LEXINGTON, Mass., Dec.
CORALVILLE, Iowa, Dec.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.